309 - Prolongation of Eosinophilic Esophagitis Treatment with Budesonide Orodispersible Tablets for Incomplete Responder is Effective and Safe: Results from a 6-Weeks Open-Label Treatment Phase of the Pivotal Trial EOS-1Alfredo J. Lucendo, Alex Straumann, Ulrike von Arnim et al.|Gastroenterology|2018Cited by 3
Development and validation of a novel patient-reported outcome for microscopic colitis—Microscopic Colitis Score (MCS)Katarina Pihl Lesnovska, Henrik Hjortswang, Samuel Schäfer et al.|Journal of Crohn s and Colitis|2025Cited by 0